CNS Anticancer Drug Discovery and Development: 2016 conference insights
Victor A. Levin(Orbus Therapeutics (United States)), James M. Gallo(Texas Tech University), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Peter J. Tonge(University of Rochester), William A. Weiss(City College of San Francisco), Lauren E. Abrey(Lymphoma Study Association), Timothy P. Heffron(Texas Tech University)
Cited by 15
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
|BMC Medicine|2008|948
Targeted expression of MYCN causes neuroblastoma in transgenic mice
|The EMBO Journal|1997|870
Neuroblastoma and MYCN
|Cold Spring Harbor Perspectives in Medicine|2013|642